DMN3 is a marketing agency that uses consumer insights to help clients increase sales in the healthcare, energy, financial, and retail industries. The DMN3 Healthcare Practice Group focuses on solving business issues for the pharmaceutical, medical device, and biotech industries, as well as hospitals and medical practices.
At DMN3, Adolph will lead strategic healthcare efforts by combining traditional direct response experience with the latest digital, mobile, and social media methods. Her efforts will focus on seamless channel integration between:
- Online, mobile, and offline promotions
- Direct-to-Consumer and closed-loop marketing
- Personal and non-personal healthcare professional promotions
Adolph’s strong executive leadership background in the pharmaceutical, biotech, and medical device industries has been proven through numerous successful product launches for pharmaceutical companies including Pfizer Inc., Roche, Eli Lilly, and AstraZeneca and medical device companies, such as C.R. Bard, Inc., ZOLL Medical Corporation, Stryker®, Candela Corporation, and Bayer Diagnostics.
“This experience will provide new insights for our clients as we launch campaigns for 2013,” Lockard said.